blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0445894

EP0445894 - Use of tumor necrosis factor [Right-click to bookmark this link]
Former [1991/37]Methods for the treatment of demyelinating disease, uveitis, or graft-versus-host-disease
[1995/06]
StatusNo opposition filed within time limit
Status updated on  04.01.1996
Database last updated on 14.09.2024
Most recent event   Tooltip04.01.1996No opposition filed within time limitpublished on 31.01.1996 [1996/05]
Applicant(s)For all designated states
ASAHI KASEI KOGYO KABUSHIKI KAISHA
2-6, Dojimahama 1-chome Kita-ku
Osaka / JP
[1991/37]
Inventor(s)01 / Otsuka, Yoshiki
Asahi Kasei 5 Ryo, 100 Kawanarijima
Fuji-shi, Shizuoka-ken 416 / JP
02 / Hori, Kazuyoshi
322-77, Iwamoto
Fuji-shi, Shizuoka-ken 416 / JP
03 / Hayashi, Hiroshi
3989-1, Imaizumi
Fuji-shi, Shizuoka-ken 417 / JP
[1991/37]
Representative(s)Smulders, Theodorus A.H.J., et al
Vereenigde Postbus 87930
2508 DH Den Haag / NL
[N/P]
Former [1991/37]Smulders, Theodorus A.H.J., Ir., et al
Vereenigde Octrooibureaux Nieuwe Parklaan 97
NL-2587 BN 's-Gravenhage / NL
Application number, filing date91200520.408.03.1991
[1991/37]
Priority number, dateJP1990005673409.03.1990         Original published format: JP 5673490
JP1990005673509.03.1990         Original published format: JP 5673590
JP1990005673609.03.1990         Original published format: JP 5673690
[1991/37]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0445894
Date:11.09.1991
Language:EN
[1991/37]
Type: A3 Search report 
No.:EP0445894
Date:02.01.1992
Language:EN
[1992/01]
Type: B1 Patent specification 
No.:EP0445894
Date:08.02.1995
Language:EN
[1995/06]
Search report(s)(Supplementary) European search report - dispatched on:EP12.11.1991
ClassificationIPC:C07K14/525, A61K38/19
[1995/06]
CPC:
A61K38/191 (EP,US)
Former IPC [1991/37]C07K15/00, A61K37/02
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1991/37]
TitleGerman:Verwendung von Tumornekrosefaktor[1995/06]
English:Use of tumor necrosis factor[1995/06]
French:Application du facteur de nécrose de tumeurs[1995/06]
Former [1991/37]Methode zur Behandlung von Demyelinisierungskrankheiten, Uveitis oder Graft-Versus-Host-Krankheiten
Former [1991/37]Methods for the treatment of demyelinating disease, uveitis, or graft-versus-host-disease
Former [1991/37]Méthode de traitement des maladies démyelinisantes, de l'uvéite et des rejets de greffe
Examination procedure08.03.1991Examination requested  [1991/37]
15.10.1992Despatch of a communication from the examining division (Time limit: M04)
14.01.1993Reply to a communication from the examining division
22.09.1993Despatch of a communication from the examining division (Time limit: M02)
29.11.1993Reply to a communication from the examining division
11.02.1994Despatch of communication of intention to grant (Approval: Yes)
01.07.1994Communication of intention to grant the patent
02.09.1994Fee for grant paid
02.09.1994Fee for publishing/printing paid
Opposition(s)09.11.1995No opposition filed within time limit [1996/05]
Fees paidRenewal fee
31.03.1993Renewal fee patent year 03
31.03.1994Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0325471  (COLLAGEN CORP [US]);
 [X]EP0308378  (YEDA RES & DEV [IL])
 [XP]  - International Immunology, Vol. 2, No. 9, 1990, USA, pages 909-913; PAYA C.V. et al.: "Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha", the whole document.
 [X]  - Journal of Immunology, Vol. 144, No. 1, 1 January 1990, pages 129-135, Baltimore, US; SELMAJ K.W. et al.: "Proliferation of strocytes in vitro in response to cytokines. A primary role for tumor necrosis factor", page 135.
 [A]  - Biosis Previews Database Biosis, Philadelphia, PA, US; KULKARNI P.S. et al.: "Cachectin a novel polypeptide induces uvcitis in the rabbit eye", & Exp. Eye. Res. 46 (4) 1988, 631-34.
 [A]  - Biosis Previews Database Biosis, Philadelphia, PA, US, Accession No. 7127480, Abstract No. 88050225; SHALABY M.R. et al.: "Prevention of graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor alpha", & Transplantation, 47 (6), 1989, 1057-1061.
 [A]  - Biosis Previews Database Biosis, Philadelphia, PA, US, Accession No. 6437344, Abstract No. 85037865; PIGUET P.F. et al.: "Tumor-necrosis factor-cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease", & J. Exp. Med. 166 (5), 1987, 1280-1289.
Examination   - Biosis Previews Database, Biosis, Philadelphia, PA, US; Kulkarni P S et al.: "Cachetin a novel polypeptide induces uvcitis in the rabbit eye"
    - Biosis Previews Database, Biosis, Philadelphia, PA, US, accession No. 6437344, Piguet P F et al.:"Tumor necrosis factor-cachetin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.